# Zevra Therapeutics, Inc.: Form DEF 14A, filed Apr 3, 2024

- Company: [Zevra Therapeutics, Inc.](/companies/zvra.md) (CIK 1434647)
- Form: DEF 14A
- Filed: 2024-04-03
- Accepted by EDGAR: Apr 3, 2024, 20:15 ET
- Period: 2024-05-13
- Accession: 0001437749-24-010874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010874/zvra20240303_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434647/000143774924010874/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434647/000143774924010874/zvra20240303_def14a.htm

Filed Apr 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-010874. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.